首页> 外文期刊>International Journal of Biomedical and Advance Research >Study of serum lipid profile in subclinical hypothyroidism
【24h】

Study of serum lipid profile in subclinical hypothyroidism

机译:亚临床甲状腺功能减退症患者血脂水平的研究

获取原文
获取外文期刊封面目录资料

摘要

Objective: It has been known that overt hypothyroidism is associated with hyperlipidemia, replacement therapy with Levothyroxine significantly reverses lipid metabolism abnormalities. But no clear consensus has been established regarding the treatment of Subclinical Hypothyroidism subjects. This is due to the fact that there are no data from large trials on whether and to what degree Subclinical Hypothyroidism affects lipid profile. This study is aimed to provide a look at the status of Lipid Profile in the case of Subclinical Hypothyroidism. Materials and Methods: Total 100 subjects were recruited and divided into 2 groups. 50 Patients with Subclinical Hypothyroidism were considered as the cases and 50 healthy people as the controls. Serum TSH was analysed by sandwich electrochemiluminescence immunoassay method. Serum cholesterol, triglyceride and HDL were estimated by enzymatic colorimetric method, LDL was calculated by using friedewald formula. Results: Serum cholesterol, LDL were higher (P0.0001) and HDL (P0.0001) was lower in Subclinical Hypothyroid patients (mean ?SD= 199.9?27.8 mg/dl, 130.0?26.3mg/dl, 44.2?9.1 mg/dl respectively) compared to healthy controls (mean ?SD= 170.1?16.8 mg/dl, 97.3?14.7 mg/dl, 54.2?10.0 mg/dl respectively). A significant correlation was found between the levels of TSH and Serum Cholesterol (r=0.5101, P0.0001), LDL (r=0.5637, P0.0001) and a significant negative correlation was found between the levels of TSH and HDL (r=-0.4525, P0.0001). Conclusion: Subclinical hypothyroidism is associated with elevated levels of Serum Total Cholesterol and LDL which is atherogenic in nature, and low level of HDL. This may further increase the risk of development of atherosclerosis.
机译:目的:已知甲状腺功能减退症与高脂血症有关,左甲状腺素替代疗法可显着逆转脂质代谢异常。但是对于亚临床甲状腺功能减退症受试者的治疗尚未建立明确的共识。这是由于以下事实:大型临床试验没有关于亚临床甲状腺功能减退症是否影响脂质谱以及在何种程度上影响脂质谱的数据。这项研究旨在提供亚临床甲状腺功能减退情况下脂质谱的状态。材料与方法:共招募100名受试者,分为2组。以亚临床甲状腺功能减退症患者50例为对照组,健康人50例为对照组。血清TSH通过夹心电化学发光免疫分析法进行分析。酶法比色法测定血清胆固醇,甘油三酸酯和高密度脂蛋白,采用弗里德瓦尔德公式计算低密度脂蛋白。结果:亚临床甲状腺功能减退患者的血清胆固醇,LDL较高(P <0.0001),HDL(P <0.0001)较低(平均?SD = 199.9?27.8 mg / dl,130.0?26.3mg / dl,44.2?9.1 mg / dl)。 d1)与健康对照相比(平均ΔSD分别为170.1-16.8mg / dl,97.3-14.7mg / dl,54.2-10.0mg / dl)。在TSH和血清胆固醇水平(r = 0.5101,P <0.0001),LDL(r = 0.5637,P <0.0001)之间发现显着相关,在TSH和HDL水平之间(r = -0.4525,P <0.0001)。结论:亚临床甲状腺功能减退症与血清总胆固醇和低密度脂蛋白水平升高有关,而胆固醇和低密度脂蛋白具有致动脉粥样硬化作用,而高密度脂蛋白水平低。这可能会进一步增加形成动脉粥样硬化的风险。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号